NATCOPHARM.NS

NATCO Pharma Limited

HealthcareDrug Manufacturers - Specialty & GenericININRPeers →Country macro →

$889.00

+0.46%Jun 19, 2026

AI Brief

Market cap

$162.45B

52w range

—

P / E

—

EPS · FY 2026

$79.21

Volume

—

Revenue · FY 2026

$40.78B

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Explain this page

Arphra AIPlain-English read on NATCO Pharma Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$889.00

Change

+2.27%

Period high

$1206.00

Period low

$792.95

Period start

$869.252025-06-24

Through 2026-06-19

Fair value

Football field →

Weighted blend

$1,764.59

— vs spot

Recommendation

n/a

3 of 3 methods

Method spread

0bull0bear

±5% threshold

Candlestick · 1Y

Open in chart workstation →

NATCOPHARM.NS

889.00+2.27%

H 1,227L 789.00MA50 1,055MA200 924.05Avg vol 1.2M

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Real Estate
+1.01%
Consumer Cyclical
+0.94%
Energy
+0.84%
Consumer Defensive
+0.82%
Financial Services
+0.23%
Basic Materials
-0.11%
Healthcare
-0.18%
Communication Services
-0.18%
Industrials
-0.47%
Technology
-0.85%
Utilities
-1.03%

Top industries (issuer's industry highlighted)

Drug Manufacturers - Specialty & Generic
+1.99%
Software - Services
+9.60%
Broadcasting
+8.34%
Travel Services
+7.87%
Computer Hardware
+4.56%
Oil & Gas Energy
-3.54%
Biotechnology
+3.28%
Electrical Equipment & Parts
-3.26%
Semiconductors
-2.12%
Communication Equipment
+2.06%
REIT - Healthcare Facilities
+2.01%
Consulting Services
-1.97%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for NATCOPHARM.NS.

Peers

No peer list available for NATCOPHARM.NS.

Total assets

$110.74B

Total debt

$7.14B

Cash & equiv

$1.99B

Operating CF

$17.68B

Free cash flow

$13.77B

Buybacks

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$40.78B	$12.3B	$14.19B	$79.21	+34.78%